OpenLB
Open Library of Bioscience
Advanced Search
Clinics in colon and rectal surgery
Dec, 2015;28 (4): 234-46.

Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy.

Ashlie Nadler, J Andrea McCart, Anand Govindarajan
Author Information
  1. Ashlie Nadler: Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada ; Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  2. J Andrea McCart: Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada ; Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  3. Anand Govindarajan: Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada ; Mount Sinai Hospital, University of Toronto, Toronto, Canada.
PMID: 26648794 DOI: 10.1055/s-0035-1564431

Abstract

A systematic review of the literature on the management of peritoneal carcinomatosis (PC) from colon cancer with cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) was undertaken using OVID Medline. Forty-six relevant studies were reviewed. Mean weighted overall morbidity following CRS and IPC was 49% (range 22-76%) and mortality was 3.6% (range 0-19%). Median overall survival ranged from 15 to 63 months, and 5-year overall survival ranged from 7 to 100%. This represents an improvement over historical treatment with systemic chemotherapy alone, even in the era of modern chemotherapeutic agents. Quality of life following surgery is initially decreased but improves with time and approaches baseline. Available data appear to support the treatment of PC from colon cancer with CRS and IPC. There is a large amount of variability among studies and few high-quality studies exist. Further studies are needed to standardize techniques.

Keywords

carcinomatosis colorectal cancer intraperitoneal chemotherapy outcomes

References

  1. Ann Surg. 2013 Jun;257(6):1065-71 [PMID: 23299520]
  2. Br J Surg. 2004 Jun;91(6):739-46 [PMID: 15164445]
  3. Ann Surg Oncol. 2007 Aug;14(8):2281-8 [PMID: 17503156]
  4. Int Semin Surg Oncol. 2005 Feb 08;2(1):3 [PMID: 15701175]
  5. J Clin Oncol. 2007 Oct 10;25(29):4575-80 [PMID: 17925551]
  6. J Surg Oncol. 2011 Apr;103(5):431-4 [PMID: 21400529]
  7. Clin Transl Oncol. 2010 Jun;12(6):437-42 [PMID: 20534399]
  8. Ann Surg Oncol. 2005 Jan;12(1):65-71 [PMID: 15827780]
  9. Eur J Surg Oncol. 2006 Feb;32(1):65-71 [PMID: 16290055]
  10. Ann Surg. 2012 Jul;256(1):125-9 [PMID: 22580942]
  11. J Clin Oncol. 2009 Feb 10;27(5):681-5 [PMID: 19103728]
  12. In Vivo. 2006 Nov-Dec;20(6A):747-50 [PMID: 17203760]
  13. In Vivo. 2009 Jan-Feb;23(1):147-50 [PMID: 19368140]
  14. Eur J Surg Oncol. 2012 Jun;38(6):509-15 [PMID: 22475555]
  15. Dis Colon Rectum. 2000 Oct;43(10):1341-6; discussion 1347-8 [PMID: 11052509]
  16. J Surg Oncol. 2012 Feb;105(2):113-8 [PMID: 21780124]
  17. J Am Coll Surg. 2006 Dec;203(6):878-86 [PMID: 17116556]
  18. J Clin Oncol. 2004 Aug 15;22(16):3284-92 [PMID: 15310771]
  19. ScientificWorldJournal. 2013 Apr 18;2013:978394 [PMID: 23710154]
  20. Ann Surg. 2008 Nov;248(5):829-35 [PMID: 18948811]
  21. Ann Surg Oncol. 2011 Dec;18(13):3673-9 [PMID: 21674272]
  22. Ann Surg Oncol. 2008 Sep;15(9):2426-32 [PMID: 18521686]
  23. Ann Surg Oncol. 2011 Jun;18(6):1560-7 [PMID: 21203904]
  24. Cancer. 2010 Aug 15;116(16):3756-62 [PMID: 20564081]
  25. World J Surg. 2010 Jan;34(1):70-8 [PMID: 19760317]
  26. Eur J Surg Oncol. 2001 Feb;27(1):65-73 [PMID: 11237495]
  27. Ann Surg. 2013 Jul;258(1):116-21 [PMID: 23207243]
  28. Ann Surg Oncol. 2004 May;11(5):518-21 [PMID: 15123461]
  29. Eur J Surg Oncol. 2005 Mar;31(2):147-52 [PMID: 15698730]
  30. J Clin Oncol. 2003 Oct 15;21(20):3737-43 [PMID: 14551293]
  31. Acta Chir Iugosl. 2006;53(2):17-21 [PMID: 17139879]
  32. Am Surg. 2011 Feb;77(2):221-30 [PMID: 21337884]
  33. J Clin Oncol. 1988 Jan;6(1):106-18 [PMID: 2826711]
  34. Ann Surg Oncol. 2003 Jun;10(5):508-13 [PMID: 12794016]
  35. Cancer Res. 1992 Mar 1;52(5):1252-8 [PMID: 1737387]
  36. J Clin Oncol. 2010 Jan 1;28(1):63-8 [PMID: 19917863]
  37. In Vivo. 2010 Jan-Feb;24(1):79-84 [PMID: 20133981]
  38. J Surg Oncol. 2009 Jan 1;99(1):9-15 [PMID: 18937291]
  39. Br J Cancer. 1994 Feb;69(2):235-41 [PMID: 8297720]
  40. Ann Surg Oncol. 2007 Feb;14(2):509-14 [PMID: 17096054]
  41. Ann Oncol. 2012 Mar;23(3):647-52 [PMID: 21685413]
  42. World J Surg. 2006 Nov;30(11):2025-32 [PMID: 17058031]
  43. Surg Oncol Clin N Am. 2003 Jul;12(3):729-39, xiii [PMID: 14567027]
  44. Ann Surg. 2007 Apr;245(4):597-603 [PMID: 17414609]
  45. Eur J Surg Oncol. 2011 Feb;37(2):148-54 [PMID: 21093205]
  46. Ann Surg Oncol. 2013 Jan;20(1):226-32 [PMID: 22868919]
  47. Br J Surg. 2004 Jun;91(6):747-54 [PMID: 15164446]
  48. Ann Surg Oncol. 2012 Jul;19(7):2186-94 [PMID: 22395983]
  49. Cancer. 2001 Jul 1;92(1):71-6 [PMID: 11443611]
  50. Eur J Surg Oncol. 2009 Oct;35(10):1078-84 [PMID: 19285828]
  51. Ann Surg Oncol. 2008 Nov;15(11):3065-72 [PMID: 18712450]
  52. Eur J Surg Oncol. 2009 Dec;35(12):1299-305 [PMID: 19632081]
  53. N Engl J Med. 2005 Feb 3;352(5):476-87 [PMID: 15689586]
  54. Ann Surg Oncol. 2004 Feb;11(2):178-86 [PMID: 14761921]
  55. Ann Surg Oncol. 2010 May;17(5):1330-6 [PMID: 20033321]
  56. J Surg Oncol. 2013 May;107(6):591-6 [PMID: 23129533]
  57. Cancer Res. 1980 Nov;40(11):4081-4 [PMID: 7471053]
  58. Br J Surg. 2002 Dec;89(12):1545-50 [PMID: 12445064]
  59. Int J Colorectal Dis. 2007 Nov;22(11):1295-300 [PMID: 17458551]
  60. Ann Surg. 2011 Aug;254(2):294-301 [PMID: 21772129]
  61. Semin Oncol. 1989 Aug;16(4 Suppl 6):83-97 [PMID: 2669141]
  62. Cancer Invest. 2005;23(2):155-72 [PMID: 15813509]
Journal Article Review
Article has an altmetric score of 5

Word Cloud

Created with Highcharts 10.0.0studiescancerCRSchemotherapyIPCoverallcarcinomatosisPCcolonsurgeryintraperitonealfollowingrangesurvivalrangedtreatmentsystematicreviewliteraturemanagementperitonealcytoreductiveundertakenusingOVIDMedlineForty-sixrelevantreviewedMeanweightedmorbidity49%22-76%mortality36%0-19%Median1563months5-year7100%representsimprovementhistoricalsystemicaloneeveneramodernchemotherapeuticagentsQualitylifeinitiallydecreasedimprovestimeapproachesbaselineAvailabledataappearsupportlargeamountvariabilityamonghigh-qualityexistneededstandardizetechniquesPeritonealCarcinomatosisColonCancer:SystematicReviewDataCytoreductionIntraperitonealChemotherapycolorectaloutcomes

Similar Articles

Cited By